NXGL NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Nexgel Inc · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data Download investor PDF
Latest close 0.44 USD
-6.9% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -49.1% below the Trend Line and sits at 1.4% of its 52-week range. The latest completed week returned -6.9%, after a -15.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.

Setup score 16 out of 100
Latest Close 0.44 USD 24 Jul 2026
1W Return -6.9% latest completed week
4W Return -15.6% short-term follow-through
12W Return -24.5% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -6.9% Latest completed week; four-week move -15.6%. Indicator stack 0/56 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 47/100 48 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -49.1% below the Trend Line and sits at 1.4% of its 52-week range. The latest completed week returned -6.9%, after a -15.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0312-week average 0.02

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -15.6% over four weeks, -24.5% over 12 weeks, and -81.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-6.9%
4W-15.6%
12W-24.5%
26W-73.7%
52W-81.4%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.43Latest activity-pressure read.
Pressure change-24.3%Four-week change in activity pressure.
Leadership-72.97Latest relative-leadership reading.
RS change-0.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength49/100Blend of value, momentum, and quality. Underlying universe rank 52; rank 1 is best.
Value49/100Relative valuation strength. Underlying universe rank 52; rank 1 is best.
Quality47/100Profitability and accounting quality. Underlying universe rank 54; rank 1 is best.
Momentum49/100Medium-term price momentum. Underlying universe rank 52; rank 1 is best.
Growth49/100Revenue and earnings growth. Underlying universe rank 52; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-15.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
38.9%
Gross profit retained from each unit of revenue.
Operating margin
-26.8%
Operating profit retained from revenue.
Free-cash-flow margin
-12.0%
Free cash flow generated from revenue.
Return on invested capital
-28.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-23.8%
Net share repurchases relative to market value.
Shareholder yield
-23.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity6 / 9

6 acquisitions and 9 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment47/100

Weighted news tone is neutral across 48 relevant articles.

2 positive · 37 neutral · 9 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-84.8%Distance below the 52-week high.
13-week volatility7.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2617 weeks finished lower.
Best week+11.1%Week of 29 May.
Worst week-27.7%Week of 13 Mar.
Latest week-6.9%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains4
Flat weeks1
Modest losses3
Sharp losses14
Recent vol7.6%13-week weekly-return volatility.
Base vol9.1%52-week weekly-return volatility.
Up/down split21/30Count of positive and negative weeks in the 52-week window.
Average skew6.1% / -9.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape19/100

Trend, activity pressure, participation, and risk combine to a 19/100 tape read.

 Indicator analysis19/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.03; No reversal markers Factors47/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 92 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment47/100

Weighted news tone is neutral across 48 relevant articles.

Nexgel Inc (NXGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution Insiders6 / 9

6 acquisitions and 9 disposals in the latest 180-day insider tape.

 Earnings13d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.44 USD-6.9%0.86 USD2.20 USD0.43-72.97163.2KOff
17 Jul 20260.47 USD-9.0%0.90 USD2.21 USD0.66-72.23724.8KOff
10 Jul 20260.52 USD-8.3%0.94 USD2.22 USD0.80-71.58578.5KOff
3 Jul 20260.56 USD8.6%0.98 USD2.23 USD0.72-69.431.2MOff
26 Jun 20260.52 USD-8.1%1.01 USD2.24 USD0.57-72.425.3MOff
19 Jun 20260.57 USD2.7%1.05 USD2.25 USD0.30-72.063.1MOff
12 Jun 20260.55 USD-1.7%1.09 USD2.27 USD-0.11-72.79897.4KOff
5 Jun 20260.56 USD-6.6%1.13 USD2.28 USD-0.44-72.46261.3KOff
29 May 20260.60 USD11.1%1.20 USD2.29 USD-0.78-72.50553.5KOff
22 May 20260.54 USD5.9%1.26 USD2.30 USD-1.11-75.081.0MOff
15 May 20260.51 USD-14.0%1.33 USD2.31 USD-1.23-76.71632.2KOff
8 May 20260.59 USD2.1%1.40 USD2.32 USD-1.30-73.64596.5KOff
1 May 20260.58 USD-10.0%1.46 USD2.33 USD-1.33-73.48710.7KOff
24 Apr 20260.65 USD2.3%1.53 USD2.34 USD-1.31-70.854.9MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.